Lv1
60 积分 2025-06-23 加入
Efficacy and safety of cAMP-biased GLP-1 receptor agonist ecnoglutide versus dulaglutide in patients with type 2 diabetes and elevated glucose concentrations on metformin monotherapy (EECOH-2): a 52-week, multicentre, open-label, non-inferiority, randomised, phase 3 trial
10天前
已完结
Association between semaglutide use and thyroid eye disease-related outcomes in autoimmune thyroiditis with type II diabetes
1个月前
已关闭
Divergent effect of diabetes on fibrosis response to semaglutide and resmetirom in noncirrhotic MASH: A meta-analysis of randomized trials
1个月前
已关闭
Screening and management of metabolic dysfunction-associated steatotic liver disease (MASLD)
1个月前
已完结
Multidisciplinary clinical practice guideline on the management of metabolic hepatic steatosis
1个月前
已完结
Economic evaluation of NT-proBNP for heart failure risk assessment in patients with type 2 diabetes in China
2个月前
已关闭
Multidisciplinary clinical practice guideline on the management of metabolic hepatic steatosis
2个月前
已完结
Continuous glucose monitoring‑derived time in range and CV are associated with elevated risk of adverse kidney outcomes for patients with type 2 diabetes
3个月前
已完结
Semaglutide Versus Dulaglutide and Liraglutide in Chinese Patients With T2DM: A Multicenter Real-World Study
3个月前
已关闭
Switching from insulin injections to degludec/liraglutide in older frail persons: 6-month body composition remodelling
3个月前
已完结
皖公网安备34019202002308
